Advanced HPV Prevention and Treatment System
Legal Citation
Summary of the Inventive Concept
A next-generation system for preventing and treating human papillomavirus (HPV) infections, utilizing cutting-edge nanotechnology, targeted microbiome modulation, and real-time monitoring to provide enhanced protection and personalized care.
Background and Problem Solved
The original patent described a method for reducing HPV incidence and prevalence using a copper-based uterine cervical device. However, this approach has limitations, including the need for frequent device replacement and potential side effects. The new inventive concept addresses these limitations by introducing a wearable, bio-compatible device that utilizes advanced nanotechnology to release therapeutic agents in a controlled manner, providing long-term protection against HPV and sexually transmitted infections.
Detailed Description of the Inventive Concept
The Advanced HPV Prevention and Treatment System comprises a wearable, bio-compatible device that incorporates advanced nanotechnology to release therapeutic agents in a controlled manner. This device can be worn on the body, providing continuous protection against HPV and sexually transmitted infections. The system also includes a targeted microbiome modulation component, which utilizes prebiotics and probiotics to enhance local immunity and reduce the risk of HPV infection. Additionally, a real-time monitoring device detects biomarkers associated with HPV infection, providing personalized recommendations for prevention and treatment. The system can be integrated with machine learning-based algorithms to provide personalized HPV risk assessment and prevention, enhancing the therapeutic efficacy of HPV vaccines through novel adjuvants and delivery systems.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in HPV prevention and treatment by incorporating advanced nanotechnology, targeted microbiome modulation, and real-time monitoring. These innovations provide a significant improvement over the original patent's copper-based device, offering enhanced protection, convenience, and personalized care.
Alternative Embodiments and Variations
Alternative embodiments of the Advanced HPV Prevention and Treatment System could include implantable devices, transdermal patches, or oral formulations. Variations of the system could target different types of HPV or sexually transmitted infections, or be adapted for use in different populations, such as men or individuals with compromised immune systems.
Potential Commercial Applications and Market
The Advanced HPV Prevention and Treatment System has significant commercial potential in the healthcare industry, particularly in the fields of gynecology, urology, and infectious disease. The system could be marketed to healthcare providers, pharmacies, and consumers, offering a unique value proposition of enhanced protection, convenience, and personalized care.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/0039 |
| A | A61 | A61F6/144 |
| A | A61 | A61K33/34 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical devices and methods for preventing sexually transmitted infections, specifically focusing on HPV prevention and treatment, involving biotechnology, nanotechnology, and personalized medical interventions
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical researcher with expertise in infectious disease prevention, device design, nanotechnology applications in medicine, and microbiome modulation techniques, holding advanced degrees and practical experience in developing medical interventions
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's core concept of HPV prevention through localized medical intervention. The advanced nanotechnology and microbiome modulation techniques represent logical technological progressions that address inherent limitations in the original copper-based device design. The systematic approach of integrating real-time monitoring and personalized risk assessment follows established medical technology development paradigms.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,675 |
|---|---|
| Title | Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections |